BioCentury
ARTICLE | Company News

Annexon, PolyTherics deal

December 16, 2013 8:00 AM UTC

Annexon partnered with PolyTherics' Antitope Ltd. subsidiary to generate antibodies to treat neurodegenerative diseases. Annexon will provide antibodies against undisclosed components of the compleme...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article